Next Generation Wound Care Products for the World
LifeScience PLUS is a leader in advanced wound care technology. We are committed to developing and marketing innovative total wound care solutions: hemostasis (bleeding control), sealant, moist dressing, contamination prevention, and fast tissue growth generation. Our patented, best-in-class flagship product—BloodSTOP® iX Advanced Hemostat with WoundHEAL®—utilizes our revolutionary technology for both acute and chronic wound care.
Applications for this technology are numerous. Our primary focus is to aid medical professionals during surgical procedures, including burn and trauma surgeries, treatment of ulcer wounds, and prehospital and emergency trauma wound care.
The BloodSTOP product family is a new generation of wound care products for surgery, emergency trauma care, paramedics, ulcers, and dental wounds. This advanced technology provides power to control bleeding and heal quickly.
BloodSTOP and BloodSTOP iX are biocompatible, nonirritating, natural, plant-based materials. Upon meeting blood or body exudates, our products:
- Adhere to a wound
- Initiate blood coagulation
- Stop bleeding fast
- Form a protective membrane layer, creating an optimal environment for fast wound healing
- Are easily removable by rinsing (water soluble) without disruption of a clotted surface
LifeScience PLUS is pleased to announce the launch of the BloodSTOP online store. You can order all of LSP’s revolutionary wound care products from this site faster and easier than before, with additional methods of payment, including all credit cards. Go to...
LifeScience PLUS (LSP) has been proud to partner with Zenni Optical for their PPE Relief Program. Zenni is donating these kits to hospitals, medical professionals, and first responders during the Covid-19 pandemic. To date, Zenni has donated over 45,000 PPE kits...
The Food and Drug Administration (FDA) point out that someone needs a blood transfusion every 2 seconds. According to Dr. Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research, “[t]he COVID-19 pandemic has caused unprecedented challenges to...
Stathis Poulakidas, MD, FACS
Division Chief of Burn Surgery
Cook County Health, Chicago, IL
Ibrahim H. Amjad, MD
Nicklaus Children’s Hospital, Miami, FL
View Full Testimonial
A 9-year-old female with unknown genetic disorders presented after multiple treatments of open wounds of the scalp, abdomen, and leg. Attempts at using Sulfamylon, Aquacel AG, Silvadene, and Gentian Violet yielded no improvement. The most worrisome component of the patent’s care was the weekly cleanings in which the patient bled over 500 ccs, requiring transfusion of two units of blood at every OR visit.
With the introduction of BloodSTOP® iX, wound debridements were able to be done limiting blood loss to <200 ccs and only requiring one unit or less of blood. With good wound care, decrease of infections secondary to IV antibiotics, and improved nutritional status, wounds started healing. Without the use of BloodSTOP iX, any type of debridement and cleaning of these wounds would not have been possible at one OR sitting.
To conclude, all prior treatments failed to stop the bleeding for the patient’s head, chest, and legs. However, her situation was controlled with BloodSTOP iX.